VolitionRx (NYSEAMERICAN:VNRX – Get Free Report) will likely be issuing its quarterly earnings data before the market opens on Monday, March 24th. Analysts expect the company to announce earnings of ($0.06) per share and revenue of $0.55 million for the quarter.
VolitionRx Stock Performance
VNRX stock opened at $0.56 on Monday. VolitionRx has a twelve month low of $0.43 and a twelve month high of $1.02. The stock has a market cap of $35.45 million, a PE ratio of -1.00 and a beta of 1.59.
VolitionRx Company Profile
Further Reading
- Five stocks we like better than VolitionRx
- Following Congress Stock Trades
- How to Build the Ultimate Everything ETF Portfolio
- What is Short Interest? How to Use It
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- 3 Fintech Stocks With Good 2021 Prospects
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for VolitionRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VolitionRx and related companies with MarketBeat.com's FREE daily email newsletter.